null

eIF1A Monoclonal Antibody (CAB20954)

SKU:
CAB20954
Product Type:
Antibody
Antibody Type:
Polyclonal Antibody
Reactivity:
Human
Mouse
Rat
Host Species:
Rabbit
Isotype:
IgG
  • Immunohistochemistry of paraffin-embedded rat brain using eIF1A Rabbit mAb at dilution of 1:50 (40x lens). Perform high pressure antigen retrieval with 10 mM citrate buffer pH 6. 0 before commencing with IHC staining protocol.
  • Immunohistochemistry of paraffin-embedded human colon carcinoma using eIF1A Rabbit mAb at dilution of 1:50 (40x lens). Perform high pressure antigen retrieval with 10 mM citrate buffer pH 6. 0 before commencing with IHC staining protocol.
  • Immunohistochemistry of paraffin-embedded mouse pancreas using eIF1A Rabbit mAb at dilution of 1:50 (40x lens). Perform high pressure antigen retrieval with 10 mM citrate buffer pH 6. 0 before commencing with IHC staining protocol.
  • Western blot analysis of extracts of various cell lines, using eIF1A antibody at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 180s.
€179 - €469
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

eIF1A Monoclonal Antibody (CAB20954)

The EIF1A Polyclonal Antibody (CAB20954) is a specialized research tool designed for the study of EIF1A, a protein involved in the initiation of protein synthesis. This antibody, produced in rabbits, exhibits high reactivity with human samples and has been validated for use in Western blot applications. By binding specifically to EIF1A, researchers can detect and analyze this protein in various cell types, making it an ideal tool for studies in molecular biology and cancer research.EIF1A plays a crucial role in the translation initiation process, promoting the binding of the initiator tRNA to the small ribosomal subunit.

Dysregulation of EIF1A expression has been implicated in various diseases, including cancer, making it a valuable target for further investigation. Understanding the function of EIF1A is essential for developing targeted therapies that can effectively modulate protein synthesis in pathological conditions.Overall, the EIF1A Polyclonal Antibody (CAB20954) offers researchers a reliable tool for studying the role of EIF1A in protein synthesis and its potential implications in disease development and progression.